Search Results - Durgin, TL

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-lb in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis

    A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-lb in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis by Touchette, Daniel R., Durgin, Tracy L., Wanke, Lee A., Goodkin, Donald E.

    Published in Clinical therapeutics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE‐RELAPSING AND SECONDARY‐PROGRESSIVE MULTIPLE SCLEROSIS: RESULTS FROM THE MIMS TRIAL

    ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE‐RELAPSING AND SECONDARY‐PROGRESSIVE MULTIPLE SCLEROSIS: RESULTS FROM THE MIMS TRIAL by Durgin, Tl, Wanke, La, Goodkin, D, Ghalie, R

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Multiple simultaneous synthesis of phenolic libraries

    Multiple simultaneous synthesis of phenolic libraries by Meyers, H V, Dilley, G J, Durgin, T L, Powers, T S, Winssinger, N A, Zhu, H, Pavia, M R

    Published in Molecular diversity
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The design and synthesis of substituted biphenyl libraries

    The design and synthesis of substituted biphenyl libraries by Pavia, Michael R., Cohen, Michael P., Dilley, Garrett J., Dubuc, Gloria R., Durgin, Tracy L., Forman, Frank W., Hediger, Mark E., Milot, Guy, Powers, Timothy S., Sucholeiki, Irving, Zhou, Shulan, Hangauer, David G.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    PPN20: ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE-RELAPSING AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS: RESULTS FROM THE MIMS TRIAL

    PPN20: ESTIMATED RESOURCE USE AND COST OF MITOXANTRONE VS PLACEBO IN PATIENTS WITH PROGRESSIVE-RELAPSING AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS: RESULTS FROM THE MIMS TRIAL by Durgin, TL, Wanke, LA, Goodkin, D, Ghalie, R

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: